The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 130K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viola, A.
Right arrow Articles by Lanzavecchia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viola, A.
Right arrow Articles by Lanzavecchia, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/11/1775/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 10, November 17, 1997 1775-1779


Brief Definitive Reports

Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering

Antonella Viola*, Mariolina Salio*, Loretta Tuosto{ddagger}, Susanne Linkert*, Oreste Acuto{ddagger}, and Antonio Lanzavecchia*

From the * Basel Institute for Immunology, 4005, Basel, Switzerland; and {ddagger} Molecular Immunology Unit Institut Pasteur, 75724 Paris Cedex 15, France

CD4 and CD8 are thought to function as coreceptors by binding to the cognate major histocompatibility complex (MHC) molecules recognized by the T cell antigen receptor (TCR) and initiating the signal transduction cascade. We report that during T cell–antigen-presenting cell interaction, triggered TCRs and coreceptors are downregulated and degraded with identical kinetics. This coordinated disappearance takes place whenever the TCR is triggered, even when the coreceptor does not engage the cognate MHC molecule and is the consequence of binding of the coreceptor-associated Lck to ZAP-70. The interaction of coreceptor and cognate MHC molecules is dispensable when T cells are stimulated by optimal ligands, but becomes crucial when suboptimal ligands are used. In the latter case the coreceptor increases the efficiency of TCR triggering without changing the activation threshold or the quality of the T cell response.


Address correspondence to Antonella Viola, Basel Institute for Immunology, Grenzacherstrasse 487, CH4005, Basel, Switzerland. Phone: 41-61-605-1210; FAX: 41-61-605-1222; E-mail: viola{at}bii.ch

The Basel Institute for Immunology was founded and is supported by F. Hoffmann La Roche Ltd., Basel, Switzerland.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS